Salem Capital Management’s Corteva CTVA Stock Holding History

Salem Capital Management’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-50,779	Closed	-$1.5M	–	70
2019 Q2	$1.5M	Buy	+50,779	New	+$1.37M	0.83%	35

Other funds holding CTVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Salem Capital Management's CTVA Position: Q3 2019 in Review

Salem Capital Management sold out of Corteva (CTVA) in Q3 2019, closing a stake of 50,779 shares — an estimated $1.5M sold.

Salem Capital Management first reported a position in CTVA in Q2 2019 and held it in 1 quarter. The position peaked at $1.5M in Q2 2019. 984 funds tracked by Wall St. Rank hold CTVA as of Q3 2019.

Salem Capital Management reported no remaining Corteva position as of Q3 2019 after selling out during the quarter.
Salem Capital Management sold 50,779 Corteva shares in Q3 2019, an estimated $1.5M.
Salem Capital Management first reported a position in Corteva in Q2 2019 and held it in 1 quarter.
Salem Capital Management's Corteva position peaked at $1.5M in Q2 2019.
984 funds tracked by Wall St. Rank held Corteva as of Q3 2019.

Based on Salem Capital Management's 13F filing for Q3 2019, filed 7 Oct 2019.